nodes	percent_of_prediction	percent_of_DWPC	metapath
Gadoxetate—ABCC3—Methotrexate—psoriatic arthritis	0.189	0.239	CbGbCtD
Gadoxetate—SLCO1B3—Methotrexate—psoriatic arthritis	0.168	0.212	CbGbCtD
Gadoxetate—ABCC4—Methotrexate—psoriatic arthritis	0.145	0.182	CbGbCtD
Gadoxetate—ABCC2—Dexamethasone—psoriatic arthritis	0.107	0.135	CbGbCtD
Gadoxetate—SLCO1B1—Methotrexate—psoriatic arthritis	0.098	0.123	CbGbCtD
Gadoxetate—ABCC2—Methotrexate—psoriatic arthritis	0.0861	0.108	CbGbCtD
Gadoxetate—Acute coronary syndrome—Prednisone—psoriatic arthritis	0.000451	0.00219	CcSEcCtD
Gadoxetate—Myocardial infarction—Prednisone—psoriatic arthritis	0.000449	0.00217	CcSEcCtD
Gadoxetate—Malaise—Prednisolone—psoriatic arthritis	0.000444	0.00215	CcSEcCtD
Gadoxetate—Dysgeusia—Triamcinolone—psoriatic arthritis	0.000443	0.00215	CcSEcCtD
Gadoxetate—Vertigo—Prednisolone—psoriatic arthritis	0.000442	0.00214	CcSEcCtD
Gadoxetate—Syncope—Prednisolone—psoriatic arthritis	0.000441	0.00214	CcSEcCtD
Gadoxetate—Back pain—Triamcinolone—psoriatic arthritis	0.000438	0.00212	CcSEcCtD
Gadoxetate—Loss of consciousness—Prednisolone—psoriatic arthritis	0.000433	0.0021	CcSEcCtD
Gadoxetate—Angiopathy—Betamethasone—psoriatic arthritis	0.000428	0.00207	CcSEcCtD
Gadoxetate—Angiopathy—Dexamethasone—psoriatic arthritis	0.000428	0.00207	CcSEcCtD
Gadoxetate—Convulsion—Prednisolone—psoriatic arthritis	0.000427	0.00207	CcSEcCtD
Gadoxetate—Arrhythmia—Dexamethasone—psoriatic arthritis	0.000422	0.00204	CcSEcCtD
Gadoxetate—Arrhythmia—Betamethasone—psoriatic arthritis	0.000422	0.00204	CcSEcCtD
Gadoxetate—Ill-defined disorder—Triamcinolone—psoriatic arthritis	0.00042	0.00204	CcSEcCtD
Gadoxetate—Ill-defined disorder—Methylprednisolone—psoriatic arthritis	0.000419	0.00203	CcSEcCtD
Gadoxetate—Discomfort—Prednisolone—psoriatic arthritis	0.000414	0.00201	CcSEcCtD
Gadoxetate—Malaise—Triamcinolone—psoriatic arthritis	0.000408	0.00198	CcSEcCtD
Gadoxetate—Malaise—Methylprednisolone—psoriatic arthritis	0.000407	0.00197	CcSEcCtD
Gadoxetate—Vertigo—Triamcinolone—psoriatic arthritis	0.000407	0.00197	CcSEcCtD
Gadoxetate—Syncope—Triamcinolone—psoriatic arthritis	0.000406	0.00197	CcSEcCtD
Gadoxetate—Vertigo—Methylprednisolone—psoriatic arthritis	0.000406	0.00197	CcSEcCtD
Gadoxetate—Syncope—Methylprednisolone—psoriatic arthritis	0.000405	0.00196	CcSEcCtD
Gadoxetate—Connective tissue disorder—Prednisone—psoriatic arthritis	0.000404	0.00196	CcSEcCtD
Gadoxetate—Oedema—Prednisolone—psoriatic arthritis	0.000402	0.00195	CcSEcCtD
Gadoxetate—Anaphylactic shock—Prednisolone—psoriatic arthritis	0.000402	0.00195	CcSEcCtD
Gadoxetate—Loss of consciousness—Triamcinolone—psoriatic arthritis	0.000398	0.00193	CcSEcCtD
Gadoxetate—Loss of consciousness—Methylprednisolone—psoriatic arthritis	0.000397	0.00192	CcSEcCtD
Gadoxetate—Shock—Prednisolone—psoriatic arthritis	0.000395	0.00192	CcSEcCtD
Gadoxetate—Cough—Triamcinolone—psoriatic arthritis	0.000395	0.00191	CcSEcCtD
Gadoxetate—Convulsion—Triamcinolone—psoriatic arthritis	0.000392	0.0019	CcSEcCtD
Gadoxetate—Tachycardia—Prednisolone—psoriatic arthritis	0.000392	0.0019	CcSEcCtD
Gadoxetate—Convulsion—Methylprednisolone—psoriatic arthritis	0.000391	0.0019	CcSEcCtD
Gadoxetate—Hyperhidrosis—Prednisolone—psoriatic arthritis	0.000388	0.00188	CcSEcCtD
Gadoxetate—Anxiety—Methylprednisolone—psoriatic arthritis	0.000383	0.00186	CcSEcCtD
Gadoxetate—Unspecified disorder of skin and subcutaneous tissue—Methylprednisolone—psoriatic arthritis	0.000382	0.00185	CcSEcCtD
Gadoxetate—Flushing—Prednisone—psoriatic arthritis	0.000381	0.00185	CcSEcCtD
Gadoxetate—Ill-defined disorder—Betamethasone—psoriatic arthritis	0.000381	0.00185	CcSEcCtD
Gadoxetate—Ill-defined disorder—Dexamethasone—psoriatic arthritis	0.000381	0.00185	CcSEcCtD
Gadoxetate—Discomfort—Triamcinolone—psoriatic arthritis	0.000381	0.00185	CcSEcCtD
Gadoxetate—Discomfort—Methylprednisolone—psoriatic arthritis	0.00038	0.00184	CcSEcCtD
Gadoxetate—Dry mouth—Triamcinolone—psoriatic arthritis	0.000377	0.00183	CcSEcCtD
Gadoxetate—Renal failure—Methotrexate—psoriatic arthritis	0.000376	0.00182	CcSEcCtD
Gadoxetate—Angiopathy—Prednisone—psoriatic arthritis	0.000373	0.00181	CcSEcCtD
Gadoxetate—Conjunctivitis—Methotrexate—psoriatic arthritis	0.000372	0.0018	CcSEcCtD
Gadoxetate—Immune system disorder—Prednisone—psoriatic arthritis	0.000371	0.0018	CcSEcCtD
Gadoxetate—Malaise—Dexamethasone—psoriatic arthritis	0.00037	0.00179	CcSEcCtD
Gadoxetate—Malaise—Betamethasone—psoriatic arthritis	0.00037	0.00179	CcSEcCtD
Gadoxetate—Oedema—Triamcinolone—psoriatic arthritis	0.000369	0.00179	CcSEcCtD
Gadoxetate—Anaphylactic shock—Triamcinolone—psoriatic arthritis	0.000369	0.00179	CcSEcCtD
Gadoxetate—Vertigo—Betamethasone—psoriatic arthritis	0.000369	0.00179	CcSEcCtD
Gadoxetate—Vertigo—Dexamethasone—psoriatic arthritis	0.000369	0.00179	CcSEcCtD
Gadoxetate—Anaphylactic shock—Methylprednisolone—psoriatic arthritis	0.000369	0.00179	CcSEcCtD
Gadoxetate—Syncope—Dexamethasone—psoriatic arthritis	0.000368	0.00178	CcSEcCtD
Gadoxetate—Syncope—Betamethasone—psoriatic arthritis	0.000368	0.00178	CcSEcCtD
Gadoxetate—Arrhythmia—Prednisone—psoriatic arthritis	0.000367	0.00178	CcSEcCtD
Gadoxetate—Infection—Triamcinolone—psoriatic arthritis	0.000367	0.00178	CcSEcCtD
Gadoxetate—Infection—Methylprednisolone—psoriatic arthritis	0.000366	0.00177	CcSEcCtD
Gadoxetate—Shock—Triamcinolone—psoriatic arthritis	0.000363	0.00176	CcSEcCtD
Gadoxetate—Shock—Methylprednisolone—psoriatic arthritis	0.000363	0.00176	CcSEcCtD
Gadoxetate—Nervous system disorder—Methylprednisolone—psoriatic arthritis	0.000362	0.00175	CcSEcCtD
Gadoxetate—Loss of consciousness—Betamethasone—psoriatic arthritis	0.000361	0.00175	CcSEcCtD
Gadoxetate—Loss of consciousness—Dexamethasone—psoriatic arthritis	0.000361	0.00175	CcSEcCtD
Gadoxetate—Paraesthesia—Prednisolone—psoriatic arthritis	0.000361	0.00175	CcSEcCtD
Gadoxetate—Tachycardia—Triamcinolone—psoriatic arthritis	0.000361	0.00175	CcSEcCtD
Gadoxetate—Tachycardia—Methylprednisolone—psoriatic arthritis	0.00036	0.00174	CcSEcCtD
Gadoxetate—Skin disorder—Methylprednisolone—psoriatic arthritis	0.000358	0.00173	CcSEcCtD
Gadoxetate—Hyperhidrosis—Triamcinolone—psoriatic arthritis	0.000357	0.00173	CcSEcCtD
Gadoxetate—Hyperhidrosis—Methylprednisolone—psoriatic arthritis	0.000356	0.00173	CcSEcCtD
Gadoxetate—Convulsion—Dexamethasone—psoriatic arthritis	0.000356	0.00172	CcSEcCtD
Gadoxetate—Convulsion—Betamethasone—psoriatic arthritis	0.000356	0.00172	CcSEcCtD
Gadoxetate—Anxiety—Betamethasone—psoriatic arthritis	0.000348	0.00169	CcSEcCtD
Gadoxetate—Anxiety—Dexamethasone—psoriatic arthritis	0.000348	0.00169	CcSEcCtD
Gadoxetate—Discomfort—Betamethasone—psoriatic arthritis	0.000346	0.00167	CcSEcCtD
Gadoxetate—Discomfort—Dexamethasone—psoriatic arthritis	0.000346	0.00167	CcSEcCtD
Gadoxetate—Hypotension—Methylprednisolone—psoriatic arthritis	0.000344	0.00167	CcSEcCtD
Gadoxetate—Vision blurred—Prednisone—psoriatic arthritis	0.000337	0.00163	CcSEcCtD
Gadoxetate—Anaphylactic shock—Dexamethasone—psoriatic arthritis	0.000335	0.00162	CcSEcCtD
Gadoxetate—Oedema—Betamethasone—psoriatic arthritis	0.000335	0.00162	CcSEcCtD
Gadoxetate—Anaphylactic shock—Betamethasone—psoriatic arthritis	0.000335	0.00162	CcSEcCtD
Gadoxetate—Oedema—Dexamethasone—psoriatic arthritis	0.000335	0.00162	CcSEcCtD
Gadoxetate—Infection—Dexamethasone—psoriatic arthritis	0.000333	0.00161	CcSEcCtD
Gadoxetate—Infection—Betamethasone—psoriatic arthritis	0.000333	0.00161	CcSEcCtD
Gadoxetate—Ill-defined disorder—Prednisone—psoriatic arthritis	0.000332	0.00161	CcSEcCtD
Gadoxetate—Paraesthesia—Triamcinolone—psoriatic arthritis	0.000332	0.00161	CcSEcCtD
Gadoxetate—Feeling abnormal—Prednisolone—psoriatic arthritis	0.000331	0.0016	CcSEcCtD
Gadoxetate—Paraesthesia—Methylprednisolone—psoriatic arthritis	0.000331	0.0016	CcSEcCtD
Gadoxetate—Shock—Betamethasone—psoriatic arthritis	0.00033	0.0016	CcSEcCtD
Gadoxetate—Shock—Dexamethasone—psoriatic arthritis	0.00033	0.0016	CcSEcCtD
Gadoxetate—Dyspnoea—Triamcinolone—psoriatic arthritis	0.000329	0.0016	CcSEcCtD
Gadoxetate—Nervous system disorder—Dexamethasone—psoriatic arthritis	0.000329	0.00159	CcSEcCtD
Gadoxetate—Nervous system disorder—Betamethasone—psoriatic arthritis	0.000329	0.00159	CcSEcCtD
Gadoxetate—Agitation—Prednisone—psoriatic arthritis	0.000329	0.00159	CcSEcCtD
Gadoxetate—Tachycardia—Betamethasone—psoriatic arthritis	0.000327	0.00159	CcSEcCtD
Gadoxetate—Tachycardia—Dexamethasone—psoriatic arthritis	0.000327	0.00159	CcSEcCtD
Gadoxetate—Hyperhidrosis—Dexamethasone—psoriatic arthritis	0.000324	0.00157	CcSEcCtD
Gadoxetate—Hyperhidrosis—Betamethasone—psoriatic arthritis	0.000324	0.00157	CcSEcCtD
Gadoxetate—Malaise—Prednisone—psoriatic arthritis	0.000323	0.00156	CcSEcCtD
Gadoxetate—Vertigo—Prednisone—psoriatic arthritis	0.000321	0.00156	CcSEcCtD
Gadoxetate—Syncope—Prednisone—psoriatic arthritis	0.000321	0.00155	CcSEcCtD
Gadoxetate—Anorexia—Dexamethasone—psoriatic arthritis	0.00032	0.00155	CcSEcCtD
Gadoxetate—Anorexia—Betamethasone—psoriatic arthritis	0.00032	0.00155	CcSEcCtD
Gadoxetate—Urticaria—Prednisolone—psoriatic arthritis	0.000319	0.00155	CcSEcCtD
Gadoxetate—Cardiac disorder—Methotrexate—psoriatic arthritis	0.000319	0.00154	CcSEcCtD
Gadoxetate—Fatigue—Triamcinolone—psoriatic arthritis	0.000319	0.00154	CcSEcCtD
Gadoxetate—Fatigue—Methylprednisolone—psoriatic arthritis	0.000318	0.00154	CcSEcCtD
Gadoxetate—Loss of consciousness—Prednisone—psoriatic arthritis	0.000314	0.00152	CcSEcCtD
Gadoxetate—Hypotension—Dexamethasone—psoriatic arthritis	0.000313	0.00152	CcSEcCtD
Gadoxetate—Hypotension—Betamethasone—psoriatic arthritis	0.000313	0.00152	CcSEcCtD
Gadoxetate—Angiopathy—Methotrexate—psoriatic arthritis	0.000312	0.00151	CcSEcCtD
Gadoxetate—Immune system disorder—Methotrexate—psoriatic arthritis	0.00031	0.0015	CcSEcCtD
Gadoxetate—Convulsion—Prednisone—psoriatic arthritis	0.00031	0.0015	CcSEcCtD
Gadoxetate—Mediastinal disorder—Methotrexate—psoriatic arthritis	0.00031	0.0015	CcSEcCtD
Gadoxetate—Chills—Methotrexate—psoriatic arthritis	0.000308	0.00149	CcSEcCtD
Gadoxetate—Feeling abnormal—Triamcinolone—psoriatic arthritis	0.000304	0.00148	CcSEcCtD
Gadoxetate—Feeling abnormal—Methylprednisolone—psoriatic arthritis	0.000304	0.00147	CcSEcCtD
Gadoxetate—Anxiety—Prednisone—psoriatic arthritis	0.000303	0.00147	CcSEcCtD
Gadoxetate—Unspecified disorder of skin and subcutaneous tissue—Prednisone—psoriatic arthritis	0.000302	0.00147	CcSEcCtD
Gadoxetate—Gastrointestinal pain—Methylprednisolone—psoriatic arthritis	0.000301	0.00146	CcSEcCtD
Gadoxetate—Paraesthesia—Dexamethasone—psoriatic arthritis	0.000301	0.00146	CcSEcCtD
Gadoxetate—Paraesthesia—Betamethasone—psoriatic arthritis	0.000301	0.00146	CcSEcCtD
Gadoxetate—Discomfort—Prednisone—psoriatic arthritis	0.000301	0.00146	CcSEcCtD
Gadoxetate—Hypersensitivity—Prednisolone—psoriatic arthritis	0.000296	0.00143	CcSEcCtD
Gadoxetate—Urticaria—Triamcinolone—psoriatic arthritis	0.000294	0.00142	CcSEcCtD
Gadoxetate—Urticaria—Methylprednisolone—psoriatic arthritis	0.000293	0.00142	CcSEcCtD
Gadoxetate—Dysgeusia—Methotrexate—psoriatic arthritis	0.000293	0.00142	CcSEcCtD
Gadoxetate—Body temperature increased—Triamcinolone—psoriatic arthritis	0.000292	0.00142	CcSEcCtD
Gadoxetate—Anaphylactic shock—Prednisone—psoriatic arthritis	0.000292	0.00141	CcSEcCtD
Gadoxetate—Oedema—Prednisone—psoriatic arthritis	0.000292	0.00141	CcSEcCtD
Gadoxetate—Abdominal pain—Methylprednisolone—psoriatic arthritis	0.000291	0.00141	CcSEcCtD
Gadoxetate—Decreased appetite—Dexamethasone—psoriatic arthritis	0.000291	0.00141	CcSEcCtD
Gadoxetate—Decreased appetite—Betamethasone—psoriatic arthritis	0.000291	0.00141	CcSEcCtD
Gadoxetate—Infection—Prednisone—psoriatic arthritis	0.00029	0.00141	CcSEcCtD
Gadoxetate—Gastrointestinal disorder—Betamethasone—psoriatic arthritis	0.000289	0.0014	CcSEcCtD
Gadoxetate—Gastrointestinal disorder—Dexamethasone—psoriatic arthritis	0.000289	0.0014	CcSEcCtD
Gadoxetate—Back pain—Methotrexate—psoriatic arthritis	0.000289	0.0014	CcSEcCtD
Gadoxetate—Fatigue—Betamethasone—psoriatic arthritis	0.000289	0.0014	CcSEcCtD
Gadoxetate—Fatigue—Dexamethasone—psoriatic arthritis	0.000289	0.0014	CcSEcCtD
Gadoxetate—Shock—Prednisone—psoriatic arthritis	0.000287	0.00139	CcSEcCtD
Gadoxetate—Nervous system disorder—Prednisone—psoriatic arthritis	0.000286	0.00139	CcSEcCtD
Gadoxetate—Tachycardia—Prednisone—psoriatic arthritis	0.000285	0.00138	CcSEcCtD
Gadoxetate—Skin disorder—Prednisone—psoriatic arthritis	0.000284	0.00137	CcSEcCtD
Gadoxetate—Hyperhidrosis—Prednisone—psoriatic arthritis	0.000282	0.00137	CcSEcCtD
Gadoxetate—Vision blurred—Methotrexate—psoriatic arthritis	0.000282	0.00137	CcSEcCtD
Gadoxetate—Anorexia—Prednisone—psoriatic arthritis	0.000278	0.00135	CcSEcCtD
Gadoxetate—Ill-defined disorder—Methotrexate—psoriatic arthritis	0.000277	0.00134	CcSEcCtD
Gadoxetate—Feeling abnormal—Betamethasone—psoriatic arthritis	0.000276	0.00134	CcSEcCtD
Gadoxetate—Feeling abnormal—Dexamethasone—psoriatic arthritis	0.000276	0.00134	CcSEcCtD
Gadoxetate—Gastrointestinal pain—Dexamethasone—psoriatic arthritis	0.000274	0.00133	CcSEcCtD
Gadoxetate—Gastrointestinal pain—Betamethasone—psoriatic arthritis	0.000274	0.00133	CcSEcCtD
Gadoxetate—Hypersensitivity—Triamcinolone—psoriatic arthritis	0.000272	0.00132	CcSEcCtD
Gadoxetate—Hypersensitivity—Methylprednisolone—psoriatic arthritis	0.000272	0.00132	CcSEcCtD
Gadoxetate—Malaise—Methotrexate—psoriatic arthritis	0.00027	0.00131	CcSEcCtD
Gadoxetate—Vertigo—Methotrexate—psoriatic arthritis	0.000269	0.0013	CcSEcCtD
Gadoxetate—Urticaria—Betamethasone—psoriatic arthritis	0.000266	0.00129	CcSEcCtD
Gadoxetate—Urticaria—Dexamethasone—psoriatic arthritis	0.000266	0.00129	CcSEcCtD
Gadoxetate—Dizziness—Prednisolone—psoriatic arthritis	0.000266	0.00129	CcSEcCtD
Gadoxetate—Asthenia—Triamcinolone—psoriatic arthritis	0.000265	0.00128	CcSEcCtD
Gadoxetate—Abdominal pain—Betamethasone—psoriatic arthritis	0.000265	0.00128	CcSEcCtD
Gadoxetate—Abdominal pain—Dexamethasone—psoriatic arthritis	0.000265	0.00128	CcSEcCtD
Gadoxetate—Body temperature increased—Betamethasone—psoriatic arthritis	0.000265	0.00128	CcSEcCtD
Gadoxetate—Body temperature increased—Dexamethasone—psoriatic arthritis	0.000265	0.00128	CcSEcCtD
Gadoxetate—Asthenia—Methylprednisolone—psoriatic arthritis	0.000264	0.00128	CcSEcCtD
Gadoxetate—Paraesthesia—Prednisone—psoriatic arthritis	0.000262	0.00127	CcSEcCtD
Gadoxetate—Pruritus—Triamcinolone—psoriatic arthritis	0.000261	0.00127	CcSEcCtD
Gadoxetate—Cough—Methotrexate—psoriatic arthritis	0.000261	0.00126	CcSEcCtD
Gadoxetate—Pruritus—Methylprednisolone—psoriatic arthritis	0.000261	0.00126	CcSEcCtD
Gadoxetate—Convulsion—Methotrexate—psoriatic arthritis	0.000259	0.00126	CcSEcCtD
Gadoxetate—Chest pain—Methotrexate—psoriatic arthritis	0.000255	0.00123	CcSEcCtD
Gadoxetate—Decreased appetite—Prednisone—psoriatic arthritis	0.000254	0.00123	CcSEcCtD
Gadoxetate—Rash—Prednisolone—psoriatic arthritis	0.000253	0.00123	CcSEcCtD
Gadoxetate—Dermatitis—Prednisolone—psoriatic arthritis	0.000253	0.00123	CcSEcCtD
Gadoxetate—Unspecified disorder of skin and subcutaneous tissue—Methotrexate—psoriatic arthritis	0.000253	0.00122	CcSEcCtD
Gadoxetate—Diarrhoea—Methylprednisolone—psoriatic arthritis	0.000252	0.00122	CcSEcCtD
Gadoxetate—Fatigue—Prednisone—psoriatic arthritis	0.000252	0.00122	CcSEcCtD
Gadoxetate—Headache—Prednisolone—psoriatic arthritis	0.000252	0.00122	CcSEcCtD
Gadoxetate—Discomfort—Methotrexate—psoriatic arthritis	0.000251	0.00122	CcSEcCtD
Gadoxetate—Constipation—Prednisone—psoriatic arthritis	0.00025	0.00121	CcSEcCtD
Gadoxetate—Dizziness—Triamcinolone—psoriatic arthritis	0.000244	0.00118	CcSEcCtD
Gadoxetate—Anaphylactic shock—Methotrexate—psoriatic arthritis	0.000244	0.00118	CcSEcCtD
Gadoxetate—Dizziness—Methylprednisolone—psoriatic arthritis	0.000244	0.00118	CcSEcCtD
Gadoxetate—Infection—Methotrexate—psoriatic arthritis	0.000242	0.00117	CcSEcCtD
Gadoxetate—Feeling abnormal—Prednisone—psoriatic arthritis	0.000241	0.00117	CcSEcCtD
Gadoxetate—Asthenia—Betamethasone—psoriatic arthritis	0.000241	0.00117	CcSEcCtD
Gadoxetate—Asthenia—Dexamethasone—psoriatic arthritis	0.000241	0.00117	CcSEcCtD
Gadoxetate—Nervous system disorder—Methotrexate—psoriatic arthritis	0.000239	0.00116	CcSEcCtD
Gadoxetate—Gastrointestinal pain—Prednisone—psoriatic arthritis	0.000239	0.00116	CcSEcCtD
Gadoxetate—Nausea—Prednisolone—psoriatic arthritis	0.000239	0.00116	CcSEcCtD
Gadoxetate—Pruritus—Dexamethasone—psoriatic arthritis	0.000237	0.00115	CcSEcCtD
Gadoxetate—Pruritus—Betamethasone—psoriatic arthritis	0.000237	0.00115	CcSEcCtD
Gadoxetate—Skin disorder—Methotrexate—psoriatic arthritis	0.000237	0.00115	CcSEcCtD
Gadoxetate—Hyperhidrosis—Methotrexate—psoriatic arthritis	0.000236	0.00114	CcSEcCtD
Gadoxetate—Vomiting—Triamcinolone—psoriatic arthritis	0.000235	0.00114	CcSEcCtD
Gadoxetate—Vomiting—Methylprednisolone—psoriatic arthritis	0.000234	0.00114	CcSEcCtD
Gadoxetate—Rash—Triamcinolone—psoriatic arthritis	0.000233	0.00113	CcSEcCtD
Gadoxetate—Dermatitis—Triamcinolone—psoriatic arthritis	0.000233	0.00113	CcSEcCtD
Gadoxetate—Anorexia—Methotrexate—psoriatic arthritis	0.000233	0.00113	CcSEcCtD
Gadoxetate—Rash—Methylprednisolone—psoriatic arthritis	0.000232	0.00113	CcSEcCtD
Gadoxetate—Dermatitis—Methylprednisolone—psoriatic arthritis	0.000232	0.00113	CcSEcCtD
Gadoxetate—Urticaria—Prednisone—psoriatic arthritis	0.000232	0.00112	CcSEcCtD
Gadoxetate—Headache—Triamcinolone—psoriatic arthritis	0.000231	0.00112	CcSEcCtD
Gadoxetate—Headache—Methylprednisolone—psoriatic arthritis	0.000231	0.00112	CcSEcCtD
Gadoxetate—Abdominal pain—Prednisone—psoriatic arthritis	0.000231	0.00112	CcSEcCtD
Gadoxetate—Body temperature increased—Prednisone—psoriatic arthritis	0.000231	0.00112	CcSEcCtD
Gadoxetate—Diarrhoea—Betamethasone—psoriatic arthritis	0.000229	0.00111	CcSEcCtD
Gadoxetate—Diarrhoea—Dexamethasone—psoriatic arthritis	0.000229	0.00111	CcSEcCtD
Gadoxetate—Hypotension—Methotrexate—psoriatic arthritis	0.000228	0.0011	CcSEcCtD
Gadoxetate—Dizziness—Dexamethasone—psoriatic arthritis	0.000222	0.00107	CcSEcCtD
Gadoxetate—Dizziness—Betamethasone—psoriatic arthritis	0.000222	0.00107	CcSEcCtD
Gadoxetate—Nausea—Triamcinolone—psoriatic arthritis	0.000219	0.00106	CcSEcCtD
Gadoxetate—Paraesthesia—Methotrexate—psoriatic arthritis	0.000219	0.00106	CcSEcCtD
Gadoxetate—Nausea—Methylprednisolone—psoriatic arthritis	0.000219	0.00106	CcSEcCtD
Gadoxetate—Dyspnoea—Methotrexate—psoriatic arthritis	0.000218	0.00105	CcSEcCtD
Gadoxetate—Hypersensitivity—Prednisone—psoriatic arthritis	0.000215	0.00104	CcSEcCtD
Gadoxetate—Vomiting—Betamethasone—psoriatic arthritis	0.000213	0.00103	CcSEcCtD
Gadoxetate—Vomiting—Dexamethasone—psoriatic arthritis	0.000213	0.00103	CcSEcCtD
Gadoxetate—Decreased appetite—Methotrexate—psoriatic arthritis	0.000212	0.00103	CcSEcCtD
Gadoxetate—Rash—Dexamethasone—psoriatic arthritis	0.000211	0.00102	CcSEcCtD
Gadoxetate—Rash—Betamethasone—psoriatic arthritis	0.000211	0.00102	CcSEcCtD
Gadoxetate—Dermatitis—Betamethasone—psoriatic arthritis	0.000211	0.00102	CcSEcCtD
Gadoxetate—Dermatitis—Dexamethasone—psoriatic arthritis	0.000211	0.00102	CcSEcCtD
Gadoxetate—Gastrointestinal disorder—Methotrexate—psoriatic arthritis	0.000211	0.00102	CcSEcCtD
Gadoxetate—Fatigue—Methotrexate—psoriatic arthritis	0.00021	0.00102	CcSEcCtD
Gadoxetate—Headache—Betamethasone—psoriatic arthritis	0.00021	0.00102	CcSEcCtD
Gadoxetate—Headache—Dexamethasone—psoriatic arthritis	0.00021	0.00102	CcSEcCtD
Gadoxetate—Asthenia—Prednisone—psoriatic arthritis	0.000209	0.00101	CcSEcCtD
Gadoxetate—Pruritus—Prednisone—psoriatic arthritis	0.000207	0.001	CcSEcCtD
Gadoxetate—Feeling abnormal—Methotrexate—psoriatic arthritis	0.000201	0.000974	CcSEcCtD
Gadoxetate—Diarrhoea—Prednisone—psoriatic arthritis	0.0002	0.000968	CcSEcCtD
Gadoxetate—Gastrointestinal pain—Methotrexate—psoriatic arthritis	0.0002	0.000967	CcSEcCtD
Gadoxetate—Nausea—Dexamethasone—psoriatic arthritis	0.000199	0.000965	CcSEcCtD
Gadoxetate—Nausea—Betamethasone—psoriatic arthritis	0.000199	0.000965	CcSEcCtD
Gadoxetate—Urticaria—Methotrexate—psoriatic arthritis	0.000194	0.000939	CcSEcCtD
Gadoxetate—Dizziness—Prednisone—psoriatic arthritis	0.000193	0.000935	CcSEcCtD
Gadoxetate—Abdominal pain—Methotrexate—psoriatic arthritis	0.000193	0.000935	CcSEcCtD
Gadoxetate—Body temperature increased—Methotrexate—psoriatic arthritis	0.000193	0.000935	CcSEcCtD
Gadoxetate—Vomiting—Prednisone—psoriatic arthritis	0.000186	0.000899	CcSEcCtD
Gadoxetate—Rash—Prednisone—psoriatic arthritis	0.000184	0.000892	CcSEcCtD
Gadoxetate—Dermatitis—Prednisone—psoriatic arthritis	0.000184	0.000891	CcSEcCtD
Gadoxetate—Headache—Prednisone—psoriatic arthritis	0.000183	0.000886	CcSEcCtD
Gadoxetate—Hypersensitivity—Methotrexate—psoriatic arthritis	0.00018	0.000871	CcSEcCtD
Gadoxetate—Asthenia—Methotrexate—psoriatic arthritis	0.000175	0.000848	CcSEcCtD
Gadoxetate—Nausea—Prednisone—psoriatic arthritis	0.000173	0.00084	CcSEcCtD
Gadoxetate—Pruritus—Methotrexate—psoriatic arthritis	0.000173	0.000836	CcSEcCtD
Gadoxetate—Diarrhoea—Methotrexate—psoriatic arthritis	0.000167	0.000809	CcSEcCtD
Gadoxetate—Dizziness—Methotrexate—psoriatic arthritis	0.000161	0.000782	CcSEcCtD
Gadoxetate—Vomiting—Methotrexate—psoriatic arthritis	0.000155	0.000752	CcSEcCtD
Gadoxetate—Rash—Methotrexate—psoriatic arthritis	0.000154	0.000745	CcSEcCtD
Gadoxetate—Dermatitis—Methotrexate—psoriatic arthritis	0.000154	0.000745	CcSEcCtD
Gadoxetate—Headache—Methotrexate—psoriatic arthritis	0.000153	0.000741	CcSEcCtD
Gadoxetate—Nausea—Methotrexate—psoriatic arthritis	0.000145	0.000702	CcSEcCtD
